Synopsys
SNPS
$493.87
-0.91%
Synopsys Inc. is a leading global provider of electronic design automation (EDA) software and semiconductor intellectual property (IP), operating within the Technology sector's Software - Infrastructure industry. The company is a dominant market leader in the EDA space, providing a comprehensive, full-flow suite of tools essential for designing complex integrated circuits and electronic systems. The current investor narrative is heavily focused on the company's strategic positioning to capitalize on the secular trends of digital transformation and the convergence of systems and semiconductor design, as major technology companies increasingly develop custom silicon in-house, driving demand for Synopsys's critical design tools and IP.…
SNPS
Synopsys
$493.87
Related headlines
Investment Opinion: Should I buy SNPS Today?
Rating & Thesis: Hold. SNPS is a high-quality growth company in a recovery phase, but current valuation and earnings volatility warrant patience for a better entry point. The lack of a clear analyst consensus rating and target price in the data adds to the uncertainty, though the recent downgrade to 'Equal Weight' by a major firm supports a neutral stance.
Supporting Evidence: The investment case is supported by explosive Q1 revenue growth of 65.5% YoY, a strong forward P/E of 29.5x that prices in a recovery, and exceptional free cash flow generation of $2.28B TTM. However, these are counterbalanced by a high trailing P/E of 54.6x, severe quarterly net income volatility (Q1 $64.7M vs. Q4 $448.7M), and a beta of 1.245 indicating above-market risk. The stock's 14.6% one-month rally suggests momentum is improving, but it remains in a broader consolidation below its 52-week high.
Risks & Conditions: The two biggest risks are a failure to stabilize quarterly profits and a valuation multiple compression in a higher-rate environment. This Hold rating would upgrade to a Buy if the forward P/E compressed toward 25x on a pullback, or if the company demonstrates consecutive quarters of stable, growing net income. It would downgrade to a Sell if revenue growth decelerates sharply below 20% or if the stock breaks below its 52-week low. Currently, the stock appears fairly valued relative to its forward growth prospects, but not cheap enough to warrant an aggressive Buy.
Sign up to view all
SNPS 12-Month Price Forecast
Synopsys is a fundamentally strong company caught in a transitional phase. Its explosive top-line growth and critical market position are undeniable strengths, but these are offset by severe profit volatility and a valuation that is not yet a clear bargain. The neutral stance reflects the high probability (50%) of a base-case scenario where the stock grinds higher within a range. Confidence is medium due to the conflicting signals between stellar revenue and unstable earnings. The stance would upgrade to bullish on evidence of profit stabilization (consecutive quarters of >$300M net income) or a pullback to a forward P/E near 25x. It would turn bearish if revenue growth decelerates below 15% or if the stock breaks key support at $376.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Synopsys's 12-month outlook, with a consensus price target around $642.03 and implied upside of +30.0% versus the current price.
Average Target
$642.03
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$395 - $642
Analyst target range
Analyst coverage for SNPS appears limited in the provided dataset, with only 7 analysts cited for revenue estimates, and no explicit consensus recommendation, target price, or Buy/Hold/Sell distribution is available. The estimated revenue for the period averages $13.35 billion, with a range from $13.17 billion to $13.51 billion, indicating a relatively tight spread and consensus on the top-line outlook. Insufficient detailed analyst coverage data (like price targets and ratings) is available in the provided inputs to calculate a precise implied upside or downside. This is atypical for a company of Synopsys's market cap ($92.7B) and suggests the data snapshot may be incomplete. Typically, a company of this size would have extensive institutional coverage; the absence of such data here limits the ability to gauge Wall Street sentiment directly. The available institutional rating actions show a mix, including a recent downgrade from Morgan Stanley to 'Equal Weight' from 'Overweight' in late February 2026, which may signal some near-term caution among certain analysts.
Bulls vs Bears: SNPS Investment Factors
The evidence for SNPS presents a classic growth-at-a-reasonable-price tension. Bullish arguments are anchored in explosive 65.5% revenue growth, a robust high-margin business model, and a more palatable forward P/E of 29.5x. Bearish concerns focus on severe quarterly earnings volatility, a still-elevated trailing valuation, and the stock's high beta, which has led to significant underperformance. Currently, the bull side has stronger evidence due to the powerful revenue acceleration and strong cash generation, which support the forward growth narrative. The single most important tension is whether the company can translate its remarkable top-line growth into stable, expanding profitability to justify its valuation, or if earnings volatility and macro sensitivity will continue to compress its multiples.
Bullish
- Explosive Q1 Revenue Growth: Q1 FY26 revenue surged 65.5% year-over-year to $2.41 billion, a significant acceleration from prior quarters. This demonstrates strong demand for Synopsys's critical EDA and IP solutions, driven by the secular trend of in-house chip design.
- Robust Profitability & Cash Flow: The company maintains a strong 73.5% gross margin and generates substantial free cash flow, with TTM FCF of $2.28 billion. This high-margin software model provides financial resilience and funds R&D and acquisitions without excessive leverage.
- Attractive Forward Valuation: The forward P/E of 29.5x is nearly half the trailing P/E of 54.6x, indicating the market expects a significant earnings recovery. This forward multiple offers a more reasonable entry point for a company with its growth profile.
- Strong Technical Recovery Momentum: The stock is up 14.6% over the past month and 14.9% over three months, significantly outperforming the SPY. This positive short-term momentum suggests a potential bottoming process after a -41% maximum drawdown.
Bearish
- Severe Earnings Volatility: Q1 FY26 net income plummeted to $64.7 million from $448.7 million in the prior quarter, highlighting significant earnings volatility and seasonality. This makes near-term profitability difficult to predict and can spook investors.
- Elevated Trailing Valuation: A trailing P/E of 54.6x is high, even for a growth stock, and trades at a premium to its industry. This leaves the stock vulnerable to multiple compression if growth expectations are not met or if interest rates rise.
- High Beta & Volatility: With a beta of 1.245, SNPS is 25% more volatile than the market, amplifying downside risk. This was evidenced by the -41% max drawdown and the stock's 27.5% underperformance vs. the SPY over the past year.
- Analyst Downgrade & Sentiment Caution: Morgan Stanley recently downgraded SNPS to 'Equal Weight' from 'Overweight' in late February 2026. This signals near-term caution among some analysts, potentially reflecting concerns about execution or valuation.
SNPS Technical Analysis
The prevailing price trend for SNPS is one of significant volatility within a broad consolidation range, following a sharp correction from earlier highs. The stock's 1-year price change is -2.34%, underperforming the broader market's 25.19% gain, indicating a challenging period. Currently trading at $502.42, the price sits at approximately 77% of its 52-week range ($376.18 to $651.73), suggesting it is in the upper-mid portion of its annual band, having recovered from lows but still well off its peak, which reflects lingering investor caution after a substantial drawdown. Recent short-term momentum shows signs of recovery, with the stock up 14.59% over the past month and 14.95% over the past three months, significantly outpacing the SPY's gains of 5.6% and 8.42%, respectively. This positive short-term divergence from the negative 1-year trend suggests a potential bottoming process or a relief rally, though it remains within the context of the larger corrective phase that saw a -41.04% maximum drawdown. Key technical support is anchored at the 52-week low of $376.18, while resistance is at the 52-week high of $651.73. A sustained breakout above the recent recovery highs near $520 would signal a more robust reversal, whereas a breakdown below the $380 level would confirm the downtrend's continuation. With a beta of 1.245, SNPS is approximately 25% more volatile than the market, which amplifies both upside and downside moves and is a critical factor for risk-adjusted portfolio sizing.
Beta
1.25
1.25x market volatility
Max Drawdown
-41.0%
Largest decline past year
52-Week Range
$376-$652
Price range past year
Annual Return
-4.3%
Cumulative gain past year
| Period | SNPS Return | S&P 500 |
|---|---|---|
| 1m | +9.9% | +3.3% |
| 3m | +11.7% | +6.9% |
| 6m | +28.1% | +12.4% |
| 1y | -4.3% | +23.4% |
| ytd | +2.8% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SNPS Fundamental Analysis
Synopsys's revenue trajectory remains robust, with the most recent Q1 FY26 revenue of $2.41 billion representing a substantial 65.5% year-over-year growth. This acceleration is evident when compared to the prior-year Q1 revenue of $1.46 billion, though it's important to note the multi-quarter trend shows some variability in growth rates, with the preceding Q4 FY25 revenue growing at a more moderate pace to $2.25 billion. The company's comprehensive portfolio, spanning EDA software and IP, is the primary growth driver, benefiting from increased semiconductor design complexity and the industry's strategic shift toward in-house chip development. The company is profitable, with Q1 FY26 net income of $64.7 million, though this represents a significant sequential decline from the $448.7 million net income in Q4 FY25, influenced by seasonal factors and investment cycles. Gross margin remains strong at 73.54% for the quarter, consistent with its high-margin software business model, and the trailing-twelve-month net margin is a healthy 18.9%. Profitability metrics like Return on Equity (ROE) stand at 4.7%, indicating efficient use of shareholder capital, albeit moderated by the recent quarterly income dip. The balance sheet and cash flow position is solid. The company maintains a healthy current ratio of 1.62 and a moderate debt-to-equity ratio of 0.50, indicating manageable financial leverage. Critically, Synopsys generates substantial free cash flow, with TTM Free Cash Flow of $2.28 billion, providing ample internal funding for growth initiatives, R&D, and strategic acquisitions without over-reliance on external financing. The strong operating cash flow of $856.8 million in the latest quarter further underscores its financial resilience.
Quarterly Revenue
$2.4B
2026-01
Revenue YoY Growth
+0.65%
YoY Comparison
Gross Margin
+0.73%
Latest Quarter
Free Cash Flow
$2.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SNPS Overvalued?
Given that Net Income is positive ($64.7M in the latest quarter), the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is elevated at 54.56x, while the forward PE is notably lower at 29.47x. This significant gap implies the market is pricing in a substantial recovery and growth in earnings over the next twelve months, reflecting expectations for improved profitability following the seasonally weaker Q1. Compared to the Software - Infrastructure industry, Synopsys's trailing PE of 54.56x trades at a premium, though a direct industry average from the provided data is not available for a quantified spread. The premium is likely justified by the company's entrenched market leadership, critical role in the semiconductor ecosystem, and exposure to high-growth secular trends like AI and custom silicon design, which support its superior growth profile and durable competitive moat. Historically, the current trailing PE of 54.56x is below the extreme highs seen in recent quarters, such as the 287.8x recorded at the end of Q1 FY26, which was an anomaly due to depressed quarterly earnings. It is, however, above the more normalized historical range observed in prior years (e.g., 17.74x to 69.47x over the last two years). This positioning suggests the stock is not at bargain-basement levels but has repriced from peak optimism to a level that still embeds growth expectations, leaving room for multiple expansion if execution meets forecasts.
PE
54.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~288x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
33.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is earnings volatility, as evidenced by the precipitous drop in Q1 FY26 net income to $64.7M from $448.7M in the prior quarter. While revenue growth is robust at 65.5% YoY, this profit instability complicates valuation and could trigger sell-offs if future quarters disappoint. The company carries a moderate debt-to-equity ratio of 0.50, which is manageable but adds financial leverage. Furthermore, the business is inherently tied to semiconductor R&D cycles; a downturn in chip design spending would directly pressure its high-margin revenue streams.
Market & Competitive Risks: The stock's elevated trailing P/E of 54.6x creates valuation compression risk, especially if growth decelerates or interest rates remain elevated, compressing multiples for all growth stocks. With a beta of 1.245, SNPS is highly sensitive to broader market swings, amplifying downside during risk-off periods. Competitive risks, while mitigated by high switching costs and a full-flow suite, persist from rivals like Cadence and Siemens EDA. The recent analyst downgrade by Morgan Stanley highlights emerging sentiment caution that could limit near-term upside.
Worst-Case Scenario: The worst-case scenario involves a combination of a semiconductor design spending slowdown, a failure to stabilize quarterly earnings, and a broader market correction. This could trigger a re-rating to a lower multiple while growth estimates are cut. The realistic downside is anchored by the 52-week low of $376.18, which represents a -25% decline from the current price of ~$502. Given the stock's history of a -41% maximum drawdown, a severe adverse scenario could see losses approach -30% to -35%, revisiting the lows of the recent correction.
FAQ
The key risks are, in order of severity: 1) Earnings Volatility: Q1 net income of $64.7M was a -86% sequential drop, creating uncertainty. 2) Valuation Compression: A high trailing P/E of 54.6x leaves the stock vulnerable if growth slows. 3) Market Sensitivity: A beta of 1.245 means SNPS falls more than the market in downturns, as seen in its -41% max drawdown. 4) Cyclical Exposure: Revenue is tied to semiconductor R&D spending, which can be cyclical. A slowdown in chip design investment would directly impact growth.
The 12-month forecast presents three scenarios. The base case (50% probability) targets a range of $500-$580, assuming revenue growth moderates but remains strong and earnings gradually improve. The bull case (30% probability) targets $600-$652, driven by sustained hyper-growth and multiple expansion. The bear case (20% probability) targets $376-$450, triggered by earnings disappointments and a market sell-off. The base case is most likely, centered on the stock grinding higher as it digests its recent recovery rally, with the key assumption being stabilization of quarterly profitability.
SNPS appears fairly valued based on forward earnings, but carries a premium on a trailing basis. The trailing P/E of 54.6x is elevated and suggests the market is pricing in perfection. However, the forward P/E of 29.5x is more palatable and implies the market expects a substantial earnings recovery over the next year. Compared to its own historical range and the software infrastructure sector, the stock is not cheap, but the valuation is justified if the company can sustain high revenue growth and stabilize profits. The current price implies the market expects strong execution on both top and bottom lines.
SNPS is a good buy for growth investors who can tolerate volatility and are confident in the long-term semiconductor design trend, but it may not be ideal for all investors at the current price. The stock offers exposure to explosive 65.5% revenue growth and a forward P/E of 29.5x, which is reasonable for its profile. However, severe quarterly earnings volatility and a high beta of 1.245 introduce significant risk. It is a good buy for those with a 2-3 year horizon who can dollar-cost average on weakness, but conservative investors should wait for more consistent profitability or a lower entry point.
SNPS is more suitable for a long-term investment horizon of 3+ years rather than short-term trading. Its value proposition is tied to multi-year secular trends in semiconductor design, which require time to play out. The stock's high beta of 1.245 and earnings volatility make it a challenging short-term trade, as prices can swing dramatically on quarterly results. It does not pay a dividend, so total return is dependent on price appreciation. Investors should be prepared to hold through volatility to capture the long-term growth story, with a suggested minimum holding period of 18-24 months to allow for business cycle fluctuations.